Top Health Tech Companies in Dublin (80)
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Strong Revenue Growth: Public disclosures indicate revenue surpassed $1B in 2023 and remained above that level in 2024–2025, with 2024 noted at roughly $1.1B. These signals point to ongoing top‑line expansion.
Product Line Growth: Recent launches and releases such as IntelliCare and the 2026.1 updates for IRIS, IRIS for Health, and Health Connect highlight an active roadmap. This cadence is presented as expanding the addressable market and creating new upsell paths.
Strong Market Position & Advantage: Industry recognition places the company as a Leader in the 2026 Gartner Magic Quadrant for Enterprise EHRs and the 2025–2026 IDC MarketScape for analytical databases, alongside multiple 2026 Best in KLAS #1 rankings. These placements signal competitive strength and buyer traction in core markets.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Profitability: Optum generated $4.0B in operating earnings in Q2 2026 with about 160 bps year‑over‑year margin expansion, and the parent raised its 2026 adjusted EPS outlook. Operating earnings also improved at Optum Insight and Optum Rx, signaling firming margin and earnings momentum.
Cost & Operational Efficiency: Operational improvements at Optum Insight and Optum Rx’s shift toward more transparent, fee‑based pricing supported better segment profitability. Margin expansion at the Optum level despite pockets of revenue softness indicates execution on efficiency initiatives.
Innovation-Driven Growth: Optum Insight introduced new AI‑enabled offerings, and Optum closed the Alegeus acquisition to expand consumer‑directed benefits capabilities. Model changes at Optum Rx toward transparent pricing further reflect product and business model innovation.
EPAM (NYSE:EPAM) is a global leader in AI transformation engineering and integrated consulting, serving Forbes Global 2000 companies and ambitious startups. With over thirty years of expertise in custom software, product and platform engineering, EPAM empowers organizations to become AI-Native enterprises, driving measurable value from innovation and digital investments. Recognized by industry benchmarks and leading analysts as a leader in...
EPAM Systems's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyst and client assessments place EPAM in the Leaders tier for custom software development and experience/design services, signaling durable competitive standing. European buyer-ranked studies citing top rankings for Application Services and General Satisfaction further reinforce execution strength in core engineering markets.
Strong Revenue Growth: Reported 2025 revenue rose to roughly $5.46B with double‑digit year‑over‑year growth and Q4 momentum, alongside a modest headcount increase. Management guides to additional growth in 2026, indicating expansion off the 2025 rebound.
Innovation-Driven Growth: The company is scaling AI‑native offerings and platforms (e.g., EPAM AI/RUN and DIALX Lab) with strong double‑digit AI revenue momentum and an ambition to exceed $600M of AI‑native revenue in 2026. Multiple cloud and AI awards and collaborations point to innovation-led pipeline and wins.
iheed is an online medical education company, built by doctors and healthcare professionals, for doctors and healthcare professionals. iheed designs develops and delivers online university accredited postgraduate education courses in partnership with the world’s leading medical universities that deliver real results for primary care teams worldwide At iheed we believe everyone should have access to a well-educated and highly skilled...
Fettle is a digital behavioral healthcare company. We provide clients easy access to a diverse range of qualified and insured mental health professionals. Fettle was founded with the ideal that mental health is a universal need and that everyone struggles sometimes. Using technology and data science coupled with a human touch; Fettle enables seamless virtual delivery of mental health support....
Eirdoc Online Doctor: Your Convenient Gateway to Quality Healthcare. Experience the ease and accessibility of online healthcare with Eirdoc Online Doctor. Our team of experienced and qualified physicians is available to provide immediate GP consultations via video or telephone, ensuring that your health remains a top priority without disrupting your busy schedule.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for...
Becton Dickinson's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is repeatedly described as a leader across core categories like syringes, prefillable drug-delivery systems, blood collection, and infusion therapy, supported by broad global reach and large installed bases. This entrenched position aids customer stickiness and supports durable demand.
Resilient & Sustainable Growth: A substantial portion of revenue comes from everyday consumables and recurring platforms, which provides steadier sales through cycles. Consistent year-over-year revenue increases and diversified end-market exposure underpin an enduring growth profile.
Future-Ready Strategy: Management is reshaping the portfolio into a pure-play MedTech company and investing in manufacturing capacity and innovation to sharpen focus on higher-value growth areas. Guidance reaffirmations and targeted segment investments indicate disciplined execution toward long-term expansion.
We enable Cardiologists to save lives through exceptional decision-making accuracy
BVI® is refocusing the future of vision. As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries. We’ve set our sights on touching the lives of millions of patients affected...
Kyan Health is an AI-powered enterprise solution that connects employee well-being with measurable business impact. Using predictive analytics, Kyan helps companies monitor and reduce risks like absenteeism, turnover, and presenteeism. With precision mental health interventions and real-time insights, Kyan proactively addresses challenges, fostering healthier, more engaged teams. Offering a global program that’s also locally relevant, Kyan provides the widest language...
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for...
Opsona Therapeutics is a leading drug development company specialising in the human immune system. Opsona is identifying new ways to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases. Opsona's drug discovery & development is focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signalling in human immunology. Since 2004, Opsona has also developed a unique and advanced pipeline...
Optum Insight provides technology-enabled services, advanced analytics, and platforms focused on the healthcare system to help customers reduce costs, manage risk and quality, and grow revenue. It aims to simplify and connect clinical, administrative, and financial processes within healthcare.
Medtronic is a global healthcare solutions company operating in approximately 160 countries. We are committed to improving lives through our medical technologies, services, and solutions. Since our beginning, 60 years ago, our Mission has remained the same: to alleviate pain, restore health, and extend life for people around the world. The Mission is our ethical framework and inspirational goal guiding...
Medtronic's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue accelerated to the fastest annual pace in a decade in FY2026, with momentum evident into the fourth quarter. Management’s outlook points to continued upper single‑digit organic expansion in the coming year.
Healthy Cash Flow: Strong free cash flow and a long-running pattern of dividend increases indicate durable cash generation. Recent dividend actions and ongoing cash returns underscore capacity to fund investment and tuck‑in M&A.
Strong Market Position & Advantage: Scale leadership at the top of global medtech by revenue, with breadth across Cardiovascular, Neuroscience, and Medical Surgical, supports resilience. Category strength in areas like cardiac pacing and ablation provides commercial leverage for new launches.
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
Zevo Health: Elevating Global Workplace Wellbeing Zevo Health is your partner in advancing workplace wellbeing worldwide. With a steadfast commitment to supporting professionals across diverse industries across the globe, we have developed a multifaceted approach empowers individuals and organizations to thrive. 1. Professional Services and Coaching: Our comprehensive suite of professional services and coaching, available onsite and online, spans mental...
Karo Healthcare delivers smart choices for everyday healthcare. We own and commercialise branded, original over-the-counter products and prescription medicines across a range of everyday categories, including intimate health; skin health; digestive health, foot health; pain, cough and cold; wellness; and specialty products. Our products are available in more than 90 countries and sold through pharmacies, retailers and via healthcare providers....
seamlessCARE Ltd. develops innovative assistive technologies that are grounded in years of health care, industry and academic research. Empathic app and API interprets the emotions of non-verbal people. This is the first of many technologies to enhance the lives of adults and children with complex needs.
At Fitbit, we created an entire industry around wearable technology with software and services to help people transform their lives for the better, from the smallest milestones to the biggest changes. 10k steps started out as a magic number and became an anthem for setting goals—but today, we take the Fitbit community well beyond it. Our global teams are on...
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and...
Sanofi's Top Stability & Growth Strengths
Strong Revenue Growth: Sales growth is described as strong, with 2025 net sales up at constant exchange rates and Q4 showing further acceleration, indicating momentum into 2026.
Profitability: Earnings expansion is described as outpacing sales growth in 2025, and 2026 guidance indicates continued profitable expansion with EPS growing slightly faster than sales.
Product Line Growth: Newer launches are scaling rapidly, with notable growth in recent pharma launches and contributions from products beyond the flagship franchise, helping broaden growth drivers.
